This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Yonghong Gao: Innovator in Pharmaceutical Compounds
Introduction
Yonghong Gao is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work focuses on enhancing the efficacy and usability of pharmaceutical formulations.
Latest Patents
Yonghong Gao holds a patent for a polymorphic form of a compound, specifically methyl (3R,6S)-6-amino-sulfonylamino-1-(thiazol-2-yl)-3-(2,3,4-trifluorophenyl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-4-formate. This patent includes details on the preparation method and various uses of the compound. The innovation aims to improve pharmaceutical compositions and their applications in medical treatments.
Career Highlights
Yonghong Gao is associated with Qilu Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His work at Qilu has allowed him to focus on research and development, contributing to advancements in drug formulation and delivery.
Collaborations
Yonghong Gao has collaborated with notable colleagues, including Jianwei Shen and Jin Zhang. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Yonghong Gao's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patent on polymorphic compounds showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile